These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27864268)

  • 1. De novo GABRG2 mutations associated with epileptic encephalopathies.
    Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
    Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.
    Hernandez CC; XiangWei W; Hu N; Shen D; Shen W; Lagrange AH; Zhang Y; Dai L; Ding C; Sun Z; Hu J; Zhu H; Jiang Y; Macdonald RL
    Brain; 2019 Jul; 142(7):1938-1954. PubMed ID: 31056671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders.
    Komulainen-Ebrahim J; Schreiber JM; Kangas SM; Pylkäs K; Suo-Palosaari M; Rahikkala E; Liinamaa J; Immonen EV; Hassinen I; Myllynen P; Rantala H; Hinttala R; Uusimaa J
    Seizure; 2019 Jul; 69():99-104. PubMed ID: 31004928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in GABRB3: From febrile seizures to epileptic encephalopathies.
    Møller RS; Wuttke TV; Helbig I; Marini C; Johannesen KM; Brilstra EH; Vaher U; Borggraefe I; Talvik I; Talvik T; Kluger G; Francois LL; Lesca G; de Bellescize J; Blichfeldt S; Chatron N; Holert N; Jacobs J; Swinkels M; Betzler C; Syrbe S; Nikanorova M; Myers CT; Larsen LH; Vejzovic S; Pendziwiat M; von Spiczak S; Hopkins S; Dubbs H; Mang Y; Mukhin K; Holthausen H; van Gassen KL; Dahl HA; Tommerup N; Mefford HC; Rubboli G; Guerrini R; Lemke JR; Lerche H; Muhle H; Maljevic S
    Neurology; 2017 Jan; 88(5):483-492. PubMed ID: 28053010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential protein structural disturbances and suppression of assembly partners produced by nonsense GABRG2 epilepsy mutations: implications for disease phenotypic heterogeneity.
    Wang J; Shen D; Xia G; Shen W; Macdonald RL; Xu D; Kang JQ
    Sci Rep; 2016 Oct; 6():35294. PubMed ID: 27762395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inflammation responses determine the variable phenotypes of epilepsy induced by GABRG2 mutations.
    Sui J; Zhan L; Ji S; Wu W; Chen Y; Yun F; Liang W; Wang J; Cao M; Shen D; Zhang Q
    CNS Neurosci Ther; 2024 Feb; 30(2):e14583. PubMed ID: 38357846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the GABRB2-Associated Neurodevelopmental Disorders.
    El Achkar CM; Harrer M; Smith L; Kelly M; Iqbal S; Maljevic S; Niturad CE; Vissers LELM; Poduri A; Yang E; Lal D; Lerche H; Møller RS; Olson HE;
    Ann Neurol; 2021 Mar; 89(3):573-586. PubMed ID: 33325057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
    Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
    Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on the mechanism of SAHA in the treatment of refractory epilepsy induced by GABRG2(F343L) mutation.
    Wang J; Wu W; Wan J; Zhan L; Chen Y; Yun F; Ji Y; Suo G; Zheng Y; Shen D; Zhang Q
    Biochem Pharmacol; 2024 Sep; 227():116449. PubMed ID: 39053637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.
    Veeramah KR; Johnstone L; Karafet TM; Wolf D; Sprissler R; Salogiannis J; Barth-Maron A; Greenberg ME; Stuhlmann T; Weinert S; Jentsch TJ; Pazzi M; Restifo LL; Talwar D; Erickson RP; Hammer MF
    Epilepsia; 2013 Jul; 54(7):1270-81. PubMed ID: 23647072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2
    Huang X; Zhou C; Tian M; Kang JQ; Shen W; Verdier K; Pimenta A; MacDonald RL
    Epilepsia; 2017 Aug; 58(8):1451-1461. PubMed ID: 28586508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epileptic encephalopathy associated GABRG2 missense mutation leads to pre- and postsynaptic defects in zebrafish.
    Zhou J; Liang W; Wang J; Chen J; Liu D; Wang X; Wu Y; Zhang Q; Shen D
    Hum Mol Genet; 2022 Sep; 31(19):3216-3230. PubMed ID: 34957497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes.
    Johnston AJ; Kang JQ; Shen W; Pickrell WO; Cushion TD; Davies JS; Baer K; Mullins JGL; Hammond CL; Chung SK; Thomas RH; White C; Smith PEM; Macdonald RL; Rees MI
    Neurobiol Dis; 2014 Apr; 64():131-141. PubMed ID: 24407264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.
    Kang JQ; Macdonald RL
    JAMA Neurol; 2016 Aug; 73(8):1009-16. PubMed ID: 27367160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for and chemogenetic modulation of comorbidities in GABRG2-deficient epilepsies.
    Zhang CQ; McMahon B; Dong H; Warner T; Shen W; Gallagher M; Macdonald RL; Kang JQ
    Epilepsia; 2019 Jun; 60(6):1137-1149. PubMed ID: 31087664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Phenylbutyrate promoted wild-type γ-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2
    Shen W; Flamm C; Delahanty AJ; Casteel E; Biven M; DeLeeuw MB; Poliquin S; Nwosu G; Randhave K; Kang JQ
    Epilepsia; 2024 Jan; 65(1):204-217. PubMed ID: 37746768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
    Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
    Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The
    Shen D; Chen J; Liu D; Shen M; Wang X; Wu Y; Ke S; Macdonald RL; Zhang Q
    Ann Transl Med; 2020 Dec; 8(23):1560. PubMed ID: 33437759
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hernandez CC; Shen Y; Hu N; Shen W; Narayanan V; Ramsey K; He W; Zou L; Macdonald RL
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of GABAA receptor variants in epilepsy.
    Maljevic S; Møller RS; Reid CA; Pérez-Palma E; Lal D; May P; Lerche H
    Curr Opin Neurol; 2019 Apr; 32(2):183-190. PubMed ID: 30664068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.